PNVL3.SA
Strong BuyFull HouseAI screen passDimed S.A. Distribuidora de Medicamentos · Healthcare · Brazil · $378M
BRL 14.51 +10.6% · close 5 Oct · scored 3 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Dimed operates the Panvel retail pharmacy chain across southern Brazil, combining consistent store expansion with steady digital sales penetration. Upward revisions in forward consensus earnings and domestic monetary easing provide supportive conditions for consumer demand and lower financing costs.
ABOUT DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS
Read
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.0B | 4.5B | 4.9B | 5.5B | 11.4% | 5.9B | 6.3B | 7.2B | 14.3% |
| EPS (BRL) | 0.58 | 0.62 | 0.71 | 0.84 | 13.1% | 0.91 | 1.14 | 1.43 | 30.4% |
| Shares | 148.5M | 148.9M | 148.8M | 149.3M | +0.5% | 149.4M | — | — | — |
| Debt | 871.5M | 1.0B | 1.2B | 1.5B | 20.0% | 1.4B | — | — | — |
| Equity | 1.1B | 1.2B | 1.2B | 1.3B | 5.0% | — | — | — | — |
| Op CF | 205.5M | 296.6M | 224.4M | 473.1M | 32.0% | 421.0M | — | — | — |
| Inv CF | -131.1M | -196.6M | -55.7M | -383.3M | — | — | — | — | — |
| Fin CF | -103.1M | -97.8M | -116.7M | -126.0M | — | — | — | — | — |
Calmer than 61% of stocks we rank over the past year (36% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PNVL3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos(you) | $378M | 97 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $323M | 95 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $268M | 98 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $459M | 85 | Strong Buy |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $176M | 98 | Strong Buy |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $522M | 82 | Strong Buy |
| DASA3.SA | Diagnósticos da América S.A. | $782M | 74 | Buy |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $89M | 89 | Strong Buy |
| FLRY3.SA | Fleury S.A. | $2.3B | 99 | Strong Buy |
| HYPE3.SA | Hypera S.A. | $3.3B | 97 | Strong Buy |
Peer medians: ROE 10.4% · P/E 12.4x · Gross margin 30.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.